| Literature DB >> 21339961 |
Fereshteh Farokhi1, Gaetane Wielgosz-Collin, Monique Clement, Jean-Michel Kornprobst, Gilles Barnathan.
Abstract
The starfish Narcissia canariensis harvested from the coasts off Dakar, Senegal, was investigated for glycolipids (GL). This report deals with the isolation, characterization and biological activity of a fraction F13-3 separated from the GL mixture and selected according to its ability to inhibit KB cell proliferation after 72 hours of treatment. Firstly, a GL mixture F13 was obtained that accounted for 1.36% of starfish biomass (dry weight) and 0.36% of total lipids. The fraction F13-3 obtained from F13 contained three homologous GL identified as peracetylated derivatives on the basis of chemical and spectroscopic evidence. These contained a β-glucopyranoside as sugar head, a 9-methyl-branched 4,8,10-triunsaturated long-chain aminoalcohol as sphingoid base and amide-linked 2-hydroxy fatty acid chains. The majority (63%) had an amide-linked 2-hydroxydocosanoic acid chain and was identified as the ophidiacerebroside-C, firstly isolated from the starfish Ophidiaster ophidiamus. The minor components of F13-3 differed by one more or one less methylene group, and corresponded to ophidiacerebroside-B and -D. We found that F13-3 displayed an interesting cytotoxic activity over 24 hours on various adherent human cancerous cell lines (multiple myeloma, colorectal adenocarcinoma and glioblastoma multiforme) with an IC(50) of around 20 μM.Entities:
Keywords: Narcissia canariensis; glycosylceramides; human cancer cell lines; in vitro anticancerous activity; starfish
Mesh:
Substances:
Year: 2010 PMID: 21339961 PMCID: PMC3039466 DOI: 10.3390/md8122988
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Glucosylceramides for Narcissia canariensis: ophidiacerebroside-B (n = 16), ophidiacerebroside-C (n = 17) and ophidiacerebroside-D (n = 18).
1H, 13C and COSY NMR spectroscopy data for peracetylated F13-3 glycolipids in CDCl3.
| Position | δH ppm, mult., | δC ppm | |
|---|---|---|---|
| NH | 6.35 (d, | - | |
| 1a | 3.95 (dd, | 67.2 | 2, 1b |
| 1b | 3.62 (dd, | 67.2 | 2, 1a |
| 2 | 4.32 (m) | 72.7 | 1a, 1b, 3, NH |
| 3 | 4.27 (d, | 50.6 | 4, 2 |
| 4 | 5.34 (m) | 128.7 | 3, 5 |
| 5 | 5.43 (dd, | 124.8 | 4, 6 |
| 6 | 2.07 (s) | 32.3 | 5, 7 |
| 7 | 2.20 (s) | 31.9 | 6, 8, 19 |
| 8 | 5.83 (m) | 136.4 | 7 |
| 9 | - | 134.2 | |
| 10 | 6.04 (d, | 134.4 | 11 |
| 11 | 5.59 (m) | 127.8 | 10, 12 |
| 12 | 2.10 (m) | 32.9 | 11, 13 |
| 19 | 1.73 (s) | 12.5 | 7, 8 |
| CH2 | 1.27 (m) | 22.7–29.7 | |
| CH3 acetates | 2.02/2.04/2.05/2.08/2.11/2.19 (6s) | 20.6–21.0 | |
| C=O acetates | 169.3/169.4/169.6/160.7/169.8/169.9 | ||
| terminal CH3 | 0.90 (t, | 14.1 | |
| 1′ | 4.49 (d, | 100.5 | 2′ |
| 2′ | 4.97 (dd, | 71.2 | 1′, 3′ |
| 3′ | 5.20 (t, | 72.7 | 2′, 4′ |
| 4′ | 5.10 (t, | 68.2 | 3′, 5′ |
| 5′ | 3.71 (m) | 71.9 | 4′, 6′a, 6′b |
| 6′a | 4.24 (d, | 61.8 | 5′, 6′b |
| 6′b | 4.16 (dd, | 61.8 | 5, 6a |
| 1″ | - | 172.2 | |
| 2″ | 5.36 (m) | 73.0 | |
| 3″ | 1.83 (m) | 31.8 | |
| 4″ | 1.40 (m) | 29.5 | |
| terminal CH3 | 0.83 (m) | 14.1 | |
IC50 measures for F13-3 (μM ± S.E., 24 h of treatment).
| IC50 | KMS-11 | HCT-116 | GBM |
|---|---|---|---|
| F13-3 | 15.2 ± 4.0 | 18 ± 3.9 | 34.6 ± 5.1 |
Figure 2Narcissia canariensis.
Figure 3Dose-response curve of F13-3 (24 h of treatment).